Article PDF
References
Abraham E G, Pinto S B, Ghosh A, Vanlandingham D L, Budd A, Higgs S, Kafatos F C, Jacobs-Lorena M and Michel K 2005 An immune-responsive serpin, SRPN6, mediates mosquito defense against malaria parasites;Proc. Natl. Acad. Sci. USA 102 16327–16322
Banumathy G, Singh V, Pavithra S R and Tatu U 2003 Heat shock protein 90 function is essential forPlasmodiumfalciparum growth in human erythrocytes;J. Biol. Chem. 16 278 18336–18345
De D, Krogstad F M, Byers L D and Krogstad D J 1998 Structure-activity relationships for antiplasmodial activity among 7-substituted 4-aminoquinolines;Med. Chem. 41 4918–4926
Eaazhisai K, Jayalakshmi R, Gayathri P, Anand R P, Sumathy K, Balaram H and Murthy M R N 2004 Crystal Structure of Fully Ligated Adenylosuccinate Synthetase fromPlasmodium falciparum;J. Mol. Biol. 335 1251–1264
Francis S E, Gluzman I Y, Oksman A, Knickerbocker A, Mueller R, Bryant M L, Sherman D R, Russell D G and Goldberg D E 1994 Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase;EMBO J. 13 306–317
Gero A M, Dunn, Brown C G, Pulenthiran M, Gorovits M, Bakos L and Weis A L 2003 New malaria chemotherapy developed by utilization of a unique parasite transport system;Curr. Pharm. Des. 9 867–877
Nzila A M, Nduati E, Mberu E K, Hopkins Sibley C, Monks S A, Winstanley P A and Watkins W M 2000 Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on KenyanPlasmodium falciparum;J. Infect. Dis. 181 2023–2028
Pavithra S R, Banumathy G, Joy O, Singh V and Tatu U 2004 Recurrent fever promotesPlasmodium falciparum development in human erythrocytes;J. Biol. Chem. 279 46692–46699
Rathod P K, Leffers N P and Young R D 1992 Molecular targets of 5-fluoroorotate in the human malaria parasite,Plasmodium falciparum;Antimicrob. Agents Chemother. 36 704–711
Reddy R C, Vatsala P G, Keshamouni V G, Padmanaban G and Rangarajan P N 2005 Curcumin for malaria therapy;Biochem. Biophys. Res. Commun. 326 472–474
Rosenthal P J 2001Protease inhibitors. Antimalarial Chemotherapy: Mechanisms of Action, Resistance, and New Directions in Drug Discovery (Totawa, NJ Humana Press) pp 325–345
Surolia N and Surolia A 2001 Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase ofPlasmodium falciparum;Nat. Med. 7 167–173
Varadharajan S, Dhanasekaran S, Rangarajan P N and Padmanaban G 2002 Involvement of d-aminolevulinate synthase in de novo heme synthesis byPlasmodium falciparum;Biochem. J. 367 321–327
Waller R F, Keeling P J, Donald R G, Striepen B, Handman E, Lang-Unnasch, Cowman A F, Besra G S, Roos D and McFadden G I 1998 Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum;Proc. Natl. Acad. Sci. USA 95 12352–12357
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tatu, U., Jain, S. & Priya, P.P. Whither genome research: Of man, mosquito and malaria. J. Biosci. 30, 567–571 (2005). https://doi.org/10.1007/BF02703554
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02703554